Track Sessions - Available on Demand
How to Get Paid for Digital Therapeutics
Current coverage trends in the U.S. and Europe, specific case studies of hurdles for DTx developers, and what is required to make a more persuasive case to payers.
Chris Wright, Consulting
Ed Pazella, Payer
Jessica Shull, DTx Alliance
Developing a New Diagnostic for a Rare Disease to Fuel Clinical Trials and Build a Market
Case study of a collaboration between a pharma company and a national diagnostics lab that led to the commercialization of a quantitative diagnostic test for HDV.
Alastair Smith, Clinical
Matt Bryant, Eiger Biopharmaceuticals
Sierra Broder, Hepatitis B Foundation
Mridula Iyer, Quest Diagnostics
What Drug Pricing Policies Can the Executive Branch Enact without Congressional Authority?
Deep dive into executive authority on healthcare policy, discuss what is and is not possible, and how things may change under a new administration.
Meg Alexander, Reputation & Risk Management
111 West Harbor Drive, Downtown
San Diego, CA 92101